Pharmaceutical Services urged patients not to discontinue their medication following a recall by Remedica, warning of serious health consequences if they do so.

A recall of Remedica drugs has created significant chaos for patients and doctors in Cyprus, with GHS doctors scrambling to switch patient prescriptions. The recall has disrupted medical treatments and caused widespread concern.

Remedica Limited is extending its voluntary recall of pharmaceutical products, initially announced on August 10, 2026, to cover two additional batches of Clonotril 2mg Tablets.

The Health Insurance Organisation (HIO) in Cyprus has confirmed that seven of the twelve Remedica products subject to a voluntary recall have no available alternative prescription, leaving patients and medical professionals struggling during the August holidays.